PPTA 2025 Annual Report
In 2025, PPTA delivered meaningful progress to advance patient access to plasma-derived therapies. Strategic advocacy, collaboration, and data-driven leadership helped strengthen the plasma ecosystem across the United States and Europe.
Read the report for information on:
- Policy and advocacy wins in the U.S. and Europe: PPTA expanded the Congressional Plasma Caucus, advanced tariff exemptions, achieved state-level wins, and elevated recognition of the plasma supply chain in EU policy.
- Science-based regulatory leadership: PPTA strengthened engagement with U.S. and European regulators, modernized guidance, protected operations, and advanced data-driven initiatives like the CORE Study.
- Advancing donor safety and patient access: New donor registries and EU access research supported stronger donor protections and evidence-based policymaking.
- Global awareness and collaboration: IPAW 2025 united donors,patients, and policymakers worldwide around the lifesaving impact of plasma donation.
Click below to read the full 2025 PPTA Annual Report.